ENDRA Life Sciences (NDRA) Total Current Liabilities (2016 - 2026)
ENDRA Life Sciences (NDRA) reported Total Current Liabilities of $835440.0 for Q1 2026, up 47.66% year-over-year from $565785.0 in Q1 2025, and up 11.25% quarter-over-quarter from $750956.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Total Current Liabilities (2016 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has 11 years of Total Current Liabilities data on file, last reported at $835440.0 in Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $835440.0, up 47.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $835440.0 (up 47.66% YoY), and the FY2025 annual result was $750956.0, up 24.08% from the prior year.
- Total Current Liabilities rose to $835440.0 in Q1 2026 per NDRA's latest filing, from $750956.0 in the prior quarter.
- Over five years, Total Current Liabilities peaked at $2.2 million in Q3 2023 and troughed at $565785.0 in Q1 2025.
- A 5-year average of $1.2 million and a median of $1.2 million in 2024 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2022 and 2024: Total Current Liabilities jumped 77.32% in 2022, then tumbled 62.48% in 2024.
- A 5-year view of Total Current Liabilities shows it stood at $1.7 million in 2022, then slumped by 46.99% to $903095.0 in 2023, then slumped by 32.98% to $605230.0 in 2024, then grew by 24.08% to $750956.0 in 2025, then gained by 11.25% to $835440.0 in 2026.
- Business Quant data shows NDRA's Total Current Liabilities at $835440.0 in Q1 2026, $750956.0 in Q4 2025, and $800307.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 2.27 Bn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 14.62 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 7.46 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 1.30 Bn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 2.27 Bn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 8.33 Bn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 558.26 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 1.57 Bn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 1.11 Bn |
| 10 | ENDRA Life Sciences | 5.25 Mn | 4.90 Mn | - | 835,440.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 835,440.00 |
| Dec 31, 2025 | 750,956.00 |
| Sep 30, 2025 | 800,307.00 |
| Jun 30, 2025 | 576,637.00 |
| Mar 31, 2025 | 565,785.00 |
| Dec 31, 2024 | 605,230.00 |
| Sep 30, 2024 | 814,045.00 |
| Jun 30, 2024 | 1.35 Mn |
| Mar 31, 2024 | 1.22 Mn |
| Dec 31, 2023 | 903,095.00 |
| Sep 30, 2023 | 2.17 Mn |
| Jun 30, 2023 | 2.03 Mn |
| Mar 31, 2023 | 1.83 Mn |
| Dec 31, 2022 | 1.70 Mn |
| Sep 30, 2022 | 1.71 Mn |
| Jun 30, 2022 | 1.50 Mn |
| Mar 31, 2022 | 1.36 Mn |
| Dec 31, 2021 | 1.54 Mn |
| Sep 30, 2021 | 1.58 Mn |
| Jun 30, 2021 | 1.64 Mn |